116 related articles for article (PubMed ID: 8572569)
1. Contrasting patterns of selenium excretion by female CD rats treated with chemically related chemopreventive organic selenocyanate compounds.
Sohni OS; Li H; Surace A; el-Bayoumy K; Upadhyaya P; Fiala ES
Anticancer Res; 1995; 15(5B):1849-56. PubMed ID: 8572569
[TBL] [Abstract][Full Text] [Related]
2. Comparative excretion and tissue distribution of selenium in mice and rats following treatment with the chemopreventive agent 1,4-phenylenebis(methylene)selenocyanate.
Sohn OS; Desai DH; Das A; Rodriguez JG; Amin SG; El-Bayoumy K
Chem Biol Interact; 2005 Feb; 151(3):193-202. PubMed ID: 15733540
[TBL] [Abstract][Full Text] [Related]
3. Excretion and tissue distribution of selenium following treatment of male F344 rats with benzylselenocyanate or sodium selenite.
Sohn OS; Blackwell L; Mathis J; Asaad WW; Reddy BS; el-Bayoumy K
Drug Metab Dispos; 1991; 19(5):865-70. PubMed ID: 1686229
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer.
Reddy BS; Wynn TT; el-Bayoumy K; Upadhyaya P; Fiala E; Rao CV
Anticancer Res; 1996; 16(3A):1123-7. PubMed ID: 8702223
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of organoselenium compounds for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Upadhyaya P; Simi B; Rao CV
Anticancer Res; 1994; 14(6B):2509-14. PubMed ID: 7872674
[TBL] [Abstract][Full Text] [Related]
6. 1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis.
Tanaka T; Makita H; Kawabata K; Mori H; El-Bayoumy K
Cancer Res; 1997 Sep; 57(17):3644-8. PubMed ID: 9288763
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds.
Shimada T; El-Bayoumy K; Upadhyaya P; Sutter TR; Guengerich FP; Yamazaki H
Cancer Res; 1997 Nov; 57(21):4757-64. PubMed ID: 9354437
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of phenylenebis(methylene)selenocyanate isomers on xenobiotic metabolizing enzymes in organs of female CD rats.
Sohn OS; Fiala ES; Upadhyaya P; Chae YH; El-Bayoumy K
Carcinogenesis; 1999 Apr; 20(4):615-21. PubMed ID: 10223189
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets.
Reddy BS; Rivenson A; El-Bayoumy K; Upadhyaya P; Pittman B; Rao CV
J Natl Cancer Inst; 1997 Apr; 89(7):506-12. PubMed ID: 9086007
[TBL] [Abstract][Full Text] [Related]
11. The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
Samaha HS; Hamid R; el-Bayoumy K; Rao CV; Reddy BS
Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):699-704. PubMed ID: 9298577
[TBL] [Abstract][Full Text] [Related]
12. Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention.
Ip C; el-Bayoumy K; Upadhyaya P; Ganther H; Vadhanavikit S; Thompson H
Carcinogenesis; 1994 Feb; 15(2):187-92. PubMed ID: 8313507
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and excretion profile of 1,4-[14C]phenylenebis(methylene)selenocyanate in the rat.
El-Bayoumy K; Upadhyaya P; Sohn OS; Rosa JG; Fiala ES
Carcinogenesis; 1998 Sep; 19(9):1603-7. PubMed ID: 9771931
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nuclear factor-kappaB DNA binding by organoselenocyanates through covalent modification of the p50 subunit.
Chen KM; Spratt TE; Stanley BA; De Cotiis DA; Bewley MC; Flanagan JM; Desai D; Das A; Fiala ES; Amin S; El-Bayoumy K
Cancer Res; 2007 Nov; 67(21):10475-83. PubMed ID: 17974991
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray.
El-Bayoumy K; Narayanan BA; Desai DH; Narayanan NK; Pittman B; Amin SG; Schwartz J; Nixon DW
Carcinogenesis; 2003 Sep; 24(9):1505-14. PubMed ID: 12844480
[TBL] [Abstract][Full Text] [Related]
16. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer.
El-Bayoumy K; Das A; Narayanan B; Narayanan N; Fiala ES; Desai D; Rao CV; Amin S; Sinha R
Carcinogenesis; 2006 Jul; 27(7):1369-76. PubMed ID: 16399772
[TBL] [Abstract][Full Text] [Related]
17. Comparative action of 1,4-phenylenebis(methylene)selenocyanate and its metabolites against 7,12-dimethylbenz[a]anthracene-DNA adduct formation in the rat and cell proliferation in rat mammary tumor cells.
El-Bayoumy K; Das A; Boyiri T; Desai D; Sinha R; Pittman B; Amin S
Chem Biol Interact; 2003 Oct; 146(2):179-90. PubMed ID: 14597131
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of mammary cancer chemoprevention by organoselenium compounds.
El-Bayoumy K; Sinha R
Mutat Res; 2004 Jul; 551(1-2):181-97. PubMed ID: 15225592
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the chemopreventive efficacies of 1,4-phenylenebis(methylene)selenocyanate and selenium-enriched yeast on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mouse.
Das A; Desai D; Pittman B; Amin S; El-Bayoumy K
Nutr Cancer; 2003; 46(2):179-85. PubMed ID: 14690794
[TBL] [Abstract][Full Text] [Related]
20. Subchronic toxicity of benzyl selenocyanate and 1,4-phenylenebis(methylene)selenocyanate in F344 rats.
Conaway CC; Upadhyaya P; Meschter CL; Kurtzke C; Marcus LA; el-Bayoumy K
Fundam Appl Toxicol; 1992 Nov; 19(4):563-74. PubMed ID: 1426715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
